Cargando…

SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.33-derived lineage named N.9 was described recently in Brazil and it’s considered a potential variant of interest (VOI) due to the presence of E484K substitution at the receptor-binding domain (RBD) of the Spike (S) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tort, Luis Fernando Lopez, Ribeiro, Ieda Pereira, Menezes, Lidiane Souza Raphael, dos Santos, Alexandre Araújo Cunha, Santos, Marta Pereira, Damasceno, Luana, Silva, Paola Cristina Resende, de Siqueira, Marilda Agudo Mendonça Teixeira, Brasil, Patricia, Bonaldo, Myrna Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577066/
https://www.ncbi.nlm.nih.gov/pubmed/34755818
http://dx.doi.org/10.1590/0074-02760210166
_version_ 1784596002665136128
author Tort, Luis Fernando Lopez
Ribeiro, Ieda Pereira
Menezes, Lidiane Souza Raphael
dos Santos, Alexandre Araújo Cunha
Santos, Marta Pereira
Damasceno, Luana
Silva, Paola Cristina Resende
de Siqueira, Marilda Agudo Mendonça Teixeira
Brasil, Patricia
Bonaldo, Myrna Cristina
author_facet Tort, Luis Fernando Lopez
Ribeiro, Ieda Pereira
Menezes, Lidiane Souza Raphael
dos Santos, Alexandre Araújo Cunha
Santos, Marta Pereira
Damasceno, Luana
Silva, Paola Cristina Resende
de Siqueira, Marilda Agudo Mendonça Teixeira
Brasil, Patricia
Bonaldo, Myrna Cristina
author_sort Tort, Luis Fernando Lopez
collection PubMed
description BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.33-derived lineage named N.9 was described recently in Brazil and it’s considered a potential variant of interest (VOI) due to the presence of E484K substitution at the receptor-binding domain (RBD) of the Spike (S) protein. OBJECTIVE: To describe the first detection of variant N.9 in Rio de Janeiro State. METHODS: SARS-CoV-2 N.9 was confirmed by quantitative reverse transcription polymerase chain reaction (qRT-PCR), whole-genome sequencing and phylogenetic analysis. FINDINGS: Here, we report two SARS-CoV-2 N.9 lineage strains in Rio de Janeiro. One of them had only the E484K substitution of the six N.9 lineage-defining mutations. Other three strains pre-defined as N.9 have the same genomic profile. These four strains are grouped within the B.1.1.33 lineage and basal to the N.9 lineage in our phylogenetic analysis, and we call them “N.9-like/B.1.1.33 + E484K”. MAIN CONCLUSIONS: The phylogenetic analysis shows four independent introductions of N.9 in the state of Rio de Janeiro in October and December 2020, January and March 2021. SARS-CoV-2 N.9 dissemination in the Rio de Janeiro could have been limited by the emergence and dominance of other variants, mainly by the lineage P.2 VOI Zeta that emerged in the same period and co-circulated with N.9, as observed in the neighboring State of São Paulo.
format Online
Article
Text
id pubmed-8577066
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Instituto Oswaldo Cruz, Ministério da Saúde
record_format MEDLINE/PubMed
spelling pubmed-85770662021-11-18 SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil Tort, Luis Fernando Lopez Ribeiro, Ieda Pereira Menezes, Lidiane Souza Raphael dos Santos, Alexandre Araújo Cunha Santos, Marta Pereira Damasceno, Luana Silva, Paola Cristina Resende de Siqueira, Marilda Agudo Mendonça Teixeira Brasil, Patricia Bonaldo, Myrna Cristina Mem Inst Oswaldo Cruz Research Article BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.33-derived lineage named N.9 was described recently in Brazil and it’s considered a potential variant of interest (VOI) due to the presence of E484K substitution at the receptor-binding domain (RBD) of the Spike (S) protein. OBJECTIVE: To describe the first detection of variant N.9 in Rio de Janeiro State. METHODS: SARS-CoV-2 N.9 was confirmed by quantitative reverse transcription polymerase chain reaction (qRT-PCR), whole-genome sequencing and phylogenetic analysis. FINDINGS: Here, we report two SARS-CoV-2 N.9 lineage strains in Rio de Janeiro. One of them had only the E484K substitution of the six N.9 lineage-defining mutations. Other three strains pre-defined as N.9 have the same genomic profile. These four strains are grouped within the B.1.1.33 lineage and basal to the N.9 lineage in our phylogenetic analysis, and we call them “N.9-like/B.1.1.33 + E484K”. MAIN CONCLUSIONS: The phylogenetic analysis shows four independent introductions of N.9 in the state of Rio de Janeiro in October and December 2020, January and March 2021. SARS-CoV-2 N.9 dissemination in the Rio de Janeiro could have been limited by the emergence and dominance of other variants, mainly by the lineage P.2 VOI Zeta that emerged in the same period and co-circulated with N.9, as observed in the neighboring State of São Paulo. Instituto Oswaldo Cruz, Ministério da Saúde 2021-11-08 /pmc/articles/PMC8577066/ /pubmed/34755818 http://dx.doi.org/10.1590/0074-02760210166 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Research Article
Tort, Luis Fernando Lopez
Ribeiro, Ieda Pereira
Menezes, Lidiane Souza Raphael
dos Santos, Alexandre Araújo Cunha
Santos, Marta Pereira
Damasceno, Luana
Silva, Paola Cristina Resende
de Siqueira, Marilda Agudo Mendonça Teixeira
Brasil, Patricia
Bonaldo, Myrna Cristina
SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil
title SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil
title_full SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil
title_fullStr SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil
title_full_unstemmed SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil
title_short SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil
title_sort sars-cov-2 variant n.9 identified in rio de janeiro, brazil
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577066/
https://www.ncbi.nlm.nih.gov/pubmed/34755818
http://dx.doi.org/10.1590/0074-02760210166
work_keys_str_mv AT tortluisfernandolopez sarscov2variantn9identifiedinriodejaneirobrazil
AT ribeiroiedapereira sarscov2variantn9identifiedinriodejaneirobrazil
AT menezeslidianesouzaraphael sarscov2variantn9identifiedinriodejaneirobrazil
AT dossantosalexandrearaujocunha sarscov2variantn9identifiedinriodejaneirobrazil
AT santosmartapereira sarscov2variantn9identifiedinriodejaneirobrazil
AT damascenoluana sarscov2variantn9identifiedinriodejaneirobrazil
AT silvapaolacristinaresende sarscov2variantn9identifiedinriodejaneirobrazil
AT desiqueiramarildaagudomendoncateixeira sarscov2variantn9identifiedinriodejaneirobrazil
AT brasilpatricia sarscov2variantn9identifiedinriodejaneirobrazil
AT bonaldomyrnacristina sarscov2variantn9identifiedinriodejaneirobrazil